Загрузка...
Effect of Pioglitazone on Cardiovascular Outcome in Diabetes and Chronic Kidney Disease
Patients with diabetes and chronic kidney disease (CKD) are at particularly high risk for cardiovascular disease (CVD). This post hoc analysis from the PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive) investigated the relationship between CKD and incident CVD in a populati...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society of Nephrology
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2391042/ https://ncbi.nlm.nih.gov/pubmed/18057215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007060678 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|